Post Profile

Mylan to pay $465 million over EpiPen Medicaid rebate dispute

(Reuters) - Mylan NV on Friday said it will pay $465 million to settle the question of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment.
read more


Related Posts

Mylan to pay $465 million over Medicaid pricing of EpiPen

Business & Finance : Mashable: Business

Mylan will pay the Department of Justice $465 million in a settlement over its pricing and classification of the EpiPen through Medicaid, the pharmaceutical company announced Friday.  Mylan, which came under fire this summer for sys...

Mylan Surges After Quickly Settling With DoJ Over EpiPen Medicaid Rebates

Business & Finance / Personal Finance : Forbes: Personal Finance

Mylan will pay $465 million to settle with the Department of Justice over its classification of EpiPen in Medicaid rebate programs.

U.S. lawmakers question Mylan's Medicaid EpiPen rebates

Health : Reuters: Health

(Reuters) - Two key U.S. congressional committee members on Friday called for an investigation into whether Mylan NV, under fire for raising the price of its EpiPen device, overcharged the government's low-income healthcare program ...

Mylan to pay $465-million settlement over Medicaid EpiPen rebates

Business & Finance : LA Times: Business

Mylan will pay $465 million to settle allegations that it overbilled Medicaid for its life-saving EpiPen allergy injection. The federal government says EpiPen is a branded drug, which means Mylan should have been paying a far higher...

EpiPen Maker Mylan To Pay $465 Million For Shifty Medicaid Billing Practices

News : Huffington Post

(Reuters) - Mylan NV on Friday said it will pay $465 million to settle the question of whether misclassification of its EpiPen emergency allergy treatment resulted in underpayment of rebates to the U.S. Medicaid healthcare program. ...


Copyright © 2016 Regator, LLC